Return to homepagePandemic Pact

DEVELOPMENT OF HYDROGEL FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    University of São Paulo

  • Principal Investigator

    Unspecified Unspecified Unspecified

  • Research Location

    Brazil

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

SARS-CoV-2 infection can result in acute lung injury and pulmonary fibrosis. The treatment of patients with pulmonary fibrosis is expensive and limited. Therefore, it is important to develop a cheaper and more accessible treatment. To this end, we are developing a decellularized extracellular matrix hydrogel produced from porcine lungs and testing its protective effect in cellular and animal models of idiopathic pulmonary fibrosis.